|
|
 |
|
Viewing report
|
|
|
|
Meningitis - Pipeline Analysis and Market Forecasts to 2016
GlobalData, March 2010, Pages: 39
Meningitis - Pipeline Analysis and Market Forecasts to 2016
Summary
“Meningitis - Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global meningitis market. The report identifies the key trends shaping and driving the global meningitis market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to bring significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global meningitis sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Scope
The scope of the report includes:
- Annualized global meningitis disease market revenues data from 2006 to 2009, forecast forward for seven years to 2016.
- Geographic markets covered in this report include the US, Europe and Rest of the World.
- Pipeline analysis data providing a split across vaccines and drugs. Key vaccine classes include conjugated and recombinant vaccines.
- Analysis of the current and future market competition in the global meningitis market. Key market players covered are Novartis, GlaxoSmithKline, Sanofi-aventis (Sanofi Pasteur), InterMune and Merck.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessments, market characterization, unmet needs and the implications for the future market associated with meningitis.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of the pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global meningitis market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global meningitis market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global meningitis market landscape? Identify, understand and capitalize.
Customers who bought this item also bought
The Infectious Disease Vaccine Pipeline - A Competitive Review
Human Vaccines - Global Strategic Business Report
Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market
Strategic Overview of the Infectious Disease Vaccine
Pharmaceutical Partnership Deal Terminations
Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
Meningitis Global Clinical Trials Review, H2, 2011
Meningitis - Pipeline Review, Q4 2010
Meningitis - Pipeline Review, Q1 2011
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
|
|
|
|
